Target mediated endocytotic drug delivery

P100537NLO3 51 ABSTRACT The present invention is in the field of Intelligent Drug Delivery. Targeted medicines have been developed thereto, using a Targeted Mediated Drug Delivery-technology. This technology leads 5 drugs selectively and specifically into diseased cells/organs, in contrast to "...

Full description

Saved in:
Bibliographic Details
Main Authors MARKWIN HENDRIK MARING, ALBERTUS GERRIT DE BOER
Format Patent
LanguageEnglish
Published 19.09.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:P100537NLO3 51 ABSTRACT The present invention is in the field of Intelligent Drug Delivery. Targeted medicines have been developed thereto, using a Targeted Mediated Drug Delivery-technology. This technology leads 5 drugs selectively and specifically into diseased cells/organs, in contrast to "dumping" drugs into the body. This technology is found to substantially increase the efficacy of disease treatment and reduce side-effects while much smaller amounts of drug(s) are required. In addition, a novel innovative approach is used that can be applied in 10 the treatment of e.g. cancers, auto-immune diseases, viral diseases, transplantation, and diseases associated with inflammation.
Bibliography:Application Number: NL20212027601